Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kester

Showing results (161-170 of 166) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 166 results.
Journal of Hematology & Oncology|February 28, 2023
Broadly applicable TCR-based therapy for multiple myeloma targeting the immunoglobulin J chainMiranda H Meeuwsen, Anne K Wouters, Tassilo L A Wachsmann, et al.
Molecular Therapy Oncolytics|November 3, 2023
Erratum: A library of cancer testis specific T cell receptors for T cell receptor gene therapyMarije A J de Rooij, Dennis F G Remst, Dirk M van der Steen, et al.
Journal of Virology|April 24, 2009
Identification of varicella-zoster virus-specific CD8 T cells in patients after T-cell-depleted allogeneic stem cell transplantationPim L J van der Heiden, Renate de Boer, Dirk M van der Steen, et al.
Cancer Immunology Research|May 19, 2025
TCR-based therapy directed against kallikrein-related peptidase 4 is safe and effective against prostate cancerRosa A van Amerongen, Sander Tuit, Dennis F G Remst, et al.
Blood|March 1, 2024
Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigensKyra J Fuchs, Marian van de Meent, M Willy Honders, et al.
Cancers|November 13, 2021
An HLA-A*11:01-Binding Neoantigen from Mutated NPM1 as Target for TCR Gene Therapy in AMLDyantha I van der Lee, Georgia Koutsoumpli, Rogier M Reijmers, et al.
Pageof 17

Showing results (161-170 of 166) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 166 results.
Journal of Hematology & Oncology|February 28, 2023
Broadly applicable TCR-based therapy for multiple myeloma targeting the immunoglobulin J chainMiranda H Meeuwsen, Anne K Wouters, Tassilo L A Wachsmann, et al.
Molecular Therapy Oncolytics|November 3, 2023
Erratum: A library of cancer testis specific T cell receptors for T cell receptor gene therapyMarije A J de Rooij, Dennis F G Remst, Dirk M van der Steen, et al.
Journal of Virology|April 24, 2009
Identification of varicella-zoster virus-specific CD8 T cells in patients after T-cell-depleted allogeneic stem cell transplantationPim L J van der Heiden, Renate de Boer, Dirk M van der Steen, et al.
Cancer Immunology Research|May 19, 2025
TCR-based therapy directed against kallikrein-related peptidase 4 is safe and effective against prostate cancerRosa A van Amerongen, Sander Tuit, Dennis F G Remst, et al.
Blood|March 1, 2024
Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigensKyra J Fuchs, Marian van de Meent, M Willy Honders, et al.
Cancers|November 13, 2021
An HLA-A*11:01-Binding Neoantigen from Mutated NPM1 as Target for TCR Gene Therapy in AMLDyantha I van der Lee, Georgia Koutsoumpli, Rogier M Reijmers, et al.
Pageof 17